VALIDIVE
Dead / Cancelled — Cancelled — Section 71 (as of 16 Jun 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79110056
- Registration number
- 4252184
- Mark type
- Word mark
- Filed
- 16 Dec 2011
- Published for opposition
- 18 Sept 2012
- Registered
- 04 Dec 2012
- Attorney of record
- Richard M. LaBarge
Goods and services
- Class 005 — Pharmaceuticals: Bio-adhesive pharmaceutical preparations with slow-release of an anti-inflammatory agent used for treating inflammatory diseases and mucitis
Owner
- Monopar Therapeutics Inc., Wilmette, IL, US
- ONXEO, FR
- BIOALLIANCE PHARMA, PARIS, FR
- BIOALLIANCE PHARMA, PARIS, FR
Prosecution history
- 17 Mar 2024 — TOTAL INVALIDATION PROCESSED BY THE IB
- 27 Feb 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 27 Feb 2024 — INVALIDATION PROCESSED
- 16 Feb 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 16 Jun 2023 — CANCELLED SECTION 71
- 30 Dec 2021 — INTERNATIONAL REGISTRATION RENEWED
- 04 Dec 2021 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 26 Jun 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 26 Jun 2019 — REGISTERED-SEC.71 ACCEPTED
- 18 Apr 2019 — CHANGE OF OWNER RECEIVED FROM IB
- 15 Apr 2019 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 15 Jan 2019 — POST REGISTRATION ACTION MAILED - SEC.71
- 09 Jan 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Nov 2018 — TEAS SECTION 71 RECEIVED
- 04 Dec 2017 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED